LANOXIN
These highlights do not include all the information needed to use LANOXIN safely and effectively. See full prescribing information for LANOXIN. LANOXIN (digoxin) tablets, for oral use Initial U.S. Approval: 1954
d91e3646-4c63-4512-ab22-db39c085c4dc
HUMAN PRESCRIPTION DRUG LABEL
Apr 12, 2022
Concordia Pharmaceuticals Inc.
DUNS: 815240092
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
digoxin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
digoxin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
digoxin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
digoxin
Product Details
FDA regulatory identification and product classification information